DARVON-N Drug Patent Profile
✉ Email this page to a colleague
When do Darvon-n patents expire, and when can generic versions of Darvon-n launch?
Darvon-n is a drug marketed by Aaipharma Llc and Xanodyne Pharm and is included in four NDAs.
The generic ingredient in DARVON-N is aspirin; propoxyphene napsylate. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene napsylate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DARVON-N?
- What are the global sales for DARVON-N?
- What is Average Wholesale Price for DARVON-N?
Summary for DARVON-N
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
What excipients (inactive ingredients) are in DARVON-N? | DARVON-N excipients list |
DailyMed Link: | DARVON-N at DailyMed |
US Patents and Regulatory Information for DARVON-N
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aaipharma Llc | DARVON-N | propoxyphene napsylate | SUSPENSION;ORAL | 016861-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aaipharma Llc | DARVON-N W/ ASA | aspirin; propoxyphene napsylate | TABLET;ORAL | 016863-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Xanodyne Pharm | DARVON-N | propoxyphene napsylate | TABLET;ORAL | 016862-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aaipharma Llc | DARVON-N W/ ASA | aspirin; propoxyphene napsylate | CAPSULE;ORAL | 016829-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |